(Q24203872)

1

0 references

Huan Song

2

0 references

Yalun Li

3

0 references

Jane Clarke

4

0 references

Gang Shi

Cochrane Database of Systematic Reviews

5

0 references

publication date

18 January 2012

0 references

published in

0 references

cites work

Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Immunology and Endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Endometriosis: abnormal endometrium and dysfunctional immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Endometriosis: aetiology, pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Pathogenesis of endometriosis: the role of defective 'immunosurveillance'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Oral contraceptives for pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Danazol for pelvic pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Pre and post-operative medical therapy for endometriosis surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Ovulation suppression for endometriosis for women with subfertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

ESHRE guideline for the diagnosis and treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Progestagens and anti-progestagens for pain associated with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Immunobiology of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Pathophysiology of mild endometriosis: review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Angiogenesis and macrophage activation in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

A cost-effective approach to the management of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Pentoxifylline versus medical therapies for subfertile women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Influence of pentoxifylline in severe male factor infertility

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in a murine model

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Epidemiology of endometriosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021

Immunomodulation of rat endometriotic implant growth and protein production

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007677.PUB3

7 January 2021